Association between venous thromboembolism and plasma levels of both soluble fibrin and plasminogen-activator inhibitor 1 in 170 patients undergoing total hip arthroplasty

Acta Orthopaedica

Volumn 83, Issue 1, 2012, Pages 14-21

  Yukizawa, Yohei ^a   Inaba, Yutaka ^b   Watanabe, Shin Ichiro ^c   Yajima, Satoshi ^c   Kobayashi, Naomi ^b   Ishida, Takashi ^a   Iwamoto, Naoyuki ^a   Choe, Hyonmin ^a   Saito, Tomoyuki ^a,b  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FONDAPARINUX; HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; TOTAL HIP PROSTHESIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTITHROMBIN III; ARTHROPLASTY, REPLACEMENT, HIP; BIOLOGICAL MARKERS; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYSACCHARIDES; PRIMARY PREVENTION; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84856882229     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.3109/17453674.2011.652886     Document Type: Article

References (24)

1. Aso Y. Plasminogen activator inhibitor (PAI)-1 in vascular infammation and thrombosis. Front Biosci 2007; 12: 2957-66.
2. Baldridge E D, Martin M A, Welling R E. Clinical signifcance of free-foat-ing venous thrombi. J Vasc Surg 1990; 11 (1): 62-7; discussion 8-9.
3. Brueckner S, Reinke U, Roth-Isigkeit A, Eleftheriadis S, Schmucker P, Siemens H J. Comparison of general and spinal anesthesia and their infuence on hemostatic markers in patients undergoing total hip arthroplasty. J Clin Anesth 2003; 15 (6): 433-40. (Pubitemid 37491079)
4. Callaghan J J, Dorr L D, Engh G A, Hanssen A D, Healy W L, Lachiewicz P F, Lonner J H, Lotke P A, Ranawat C S, Ritter M A, Salvati E A, Sculco T P, Thornhill T S. Prophylaxis for thromboembolic disease: recommendations from the American College of Chest Physicians-are they appropriate for orthopaedic surgery? J Arthroplasty 2005; 20 (3): 273-4. (Pubitemid 40460790)
5. Cofrancesco E, Cortellaro M, Corradi A, Ravasi F, Bertocchi F. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement. Thromb Haemost 1998; 79 (3): 509-10. (Pubitemid 28120780)
6. Dorr L D, Gendelman V, Maheshwari A V, Boutary M, Wan Z, Long W T. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment. J Bone Joint Surg (Am) 2007; 89 (12): 2648-57. (Pubitemid 350230619)
7. Duwe K M, Shiau M, Budorick N E, Austin J H, Berkmen Y M. Evaluation of the lower extremity veins in patients with suspected pulmonary embolism: a retrospective comparison of helical CT venography and sonography. 2000 ARRS Executive Council Award I. American Roentgen Ray Society. AJR Am J Roentgenol 2000; 175 (6): 1525-31.
8. Fuji T, Fujita S, Ochi T. Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients. Int Orthop 2008; 32 (4): 443-51. (Pubitemid 351904622)
9. Fujita S, Hirota S, Oda T, Kato Y, Tsukamoto Y, Fuji T. Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan. Clin Orthop 2000; (375): 168-74. (Pubitemid 30366587)
10. Geerts W H, Bergqvist D, Pineo G F, Heit J A, Samama C M, Lassen M R, Colwell C W. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (6 Suppl) 2008; 133: 381S-453S. (Pubitemid 351894916)
11. Hamano A, Umeda M, Ueno Y, Tanaka S, Mimuro J, Sakata Y. Latex immu-noturbidimetric assay for soluble fbrin complex. Clin Chem 2005; 51 (1): 183-8. (Pubitemid 40024029)
12. Hamsten A, de Faire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blom-back M, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2 (8549): 3-9. (Pubitemid 17083665)
13. Husted H, Otte K S, Kristensen B B, Orsnes T, Wong C, Kehlet H. Low risk of thromboembolic complications after fast-track hip and knee arthroplasty. Acta Orthop 2010; 81 (5): 599-605.
14. Juhan-Vague I, Valadier J, Alessi M C, Aillaud M F, Ansaldi J, Philip-Joet C, Holvoet P, Serradimigni A, Collen D. Defcient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemost 1987; 57 (1): 67-72. (Pubitemid 17159602)
15. Kassis J, Hirsh J, Podor T J. Evidence that postoperative fbrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis. Blood 1992; 80 (7): 1758-64.
16. Labropoulos N, Kang S S, Mansour M A, Giannoukas A D, Moutzouros V, Baker W H. Early thrombus remodelling of isolated calf deep vein thrombosis. Eur J Vasc Endovasc Surg 2002; 23 (4): 344-8. (Pubitemid 41079446)
17. Lim K E, Hsu W C, Hsu Y Y, Chu P H, Ng C J. Deep venous thrombosis: comparison of indirect multidetector CT venography and sonography of lower extremities in 26 patients. Clin Imaging 2004; 28 (6): 439-44.
18. Loud P A, Katz D S, Bruce D A, Klippenstein D L, Grossman Z D. Deep venous thrombosis with suspected pulmonary embolism: detection with combined CT venography and pulmonary angiography. Radiology 2001; 219 (2): 498-502. (Pubitemid 32336368)
19. Niimi R, Hasegawa M, Sudo A, Shi D, Yamada T, Uchida A. Evaluation of soluble fbrin and D-dimer in the diagnosis of postoperative deep vein thrombosis. Biomarkers 2010; 15 (2): 149-57.
20. Ridker P M, Goldhaber S Z, Danielson E, Rosenberg Y, Eby C S, Deitcher S R, Cushman M, Moll S, Kessler C M, Elliott C G, Paulson R, Wong T, Bauer K A, Schwartz B A, Miletich J P, Bounameaux H, Glynn R J. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003; 348 (15): 1425-34. (Pubitemid 36407171)
21. Sharrock N E, Go G, Sculco T P, Salvati E A, Westrich G H, Harpel P C. Dose response of intravenous heparin on markers of thrombosis during primary total hip replacement. Anesthesiology 1999; 90 (4): 981-7. (Pubitemid 29159753)
22. Sudo A, Wada H, Nobori T, Yamada N, Ito M, Niimi R, Hasegawa M, Suzuki K, Uchida A. Cut-off values of D-dimer and soluble fbrin for prediction of deep vein thrombosis after orthopaedic surgery. Int J Hematol 2009; 89 (5): 572-6.
23. Sugano N, Miki H, Nakamura N, Aihara M, Yamamoto K, Ohzono K. Clinical effcacy of mechanical thromboprophylaxis without anticoagulant drugs for elective hip surgery in an Asian population. J Arthroplasty 2009; 24 (8): 1254-7.
24. The frst edition guidelines for prevention of venous thromboembolism. Tokyo [in Japanese]: Medical Front International Limited; 2004.